Atrium-targeted drug delivery through an amiodarone-eluting bilayered patch

Journal of Thoracic and Cardiovascular Surgery

Volumn 140, Issue 4, 2010, Pages 904-910

  Bolderman, Robert W ^a   Bruin, Peter ^b   Hermans, J J Rob ^a   Boerakker, Mark J ^b   Dias, Aylvin A ^b   Van Der Veen, Frederik H ^a   Maessen, Jos G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b DSM Biomedical   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; GLYCOL; POLYCAPROLACTONE; ANTIARRHYTHMIC AGENT; DRUG CARRIER; DRUG DOSAGE FORM; MACROGOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG TOLERABILITY; EPICARDIUM; FOLLOW UP; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART PACING; NONHUMAN; PRIORITY JOURNAL; ACTION POTENTIAL; ANIMAL; ATRIAL FIBRILLATION; CHEMISTRY; DISEASE MODEL; DRUG DOSAGE FORM; DRUG EFFECTS; DRUG FORMULATION; GOAT; HEART ATRIUM; KINETICS; METABOLISM; PATHOPHYSIOLOGY; PERICARDIUM; TISSUE DISTRIBUTION; TOPICAL DRUG ADMINISTRATION; TOXICITY;

ACTION POTENTIALS; ADMINISTRATION, TOPICAL; AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; DISEASE MODELS, ANIMAL; DOSAGE FORMS; DRUG CARRIERS; DRUG COMPOUNDING; GOATS; HEART ATRIA; KINETICS; PERICARDIUM; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION;

EID: 77956880937     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.01.021     Document Type: Article

References (25)

1. C.W. Hogue Jr., L.L. Creswell, D.D. Gutterman, and L.A. Fleisher Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery Chest 128 suppl 2005 9S 16S
2. N. Echahidi, P. Pibarot, G. O'Hara, and P. Mathieu Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery J Am Coll Cardiol 51 2008 793 801
3. V. Fuster, L.E. Ryden, D.S. Cannom, H.J. Crijns, A.B. Curtis, and K.A. Ellenbogen ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
4. A.J. Camm Safety considerations in the pharmacological management of atrial fibrillation Int J Cardiol 127 2008 299 306
5. L.B. Mitchell, D.V. Exner, D.G. Wyse, C.J. Connolly, G.D. Prystai, and A.J. Bayes Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial JAMA 294 2005 3093 3100
6. G.M. Ayers, T.H. Rho, J. Ben-David, H.R. Besch, and D.P. Zipes Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation J Cardiovasc Electrophysiol 7 1996 713 721
7. J.T. Darsinos, J.N. Karli, E.C. Samouilidou, B. Krumbholz, A.C. Pistevos, and G.M. Levis Distribution of amiodarone in heart tissues following intrapericardial administration Int J Clin Pharmacol Ther 37 1999 301 306
8. R.W. Bolderman, J.J. Hermans, L.M. Rademakers, T.S. Jansen, S. Verheule, and F.H. van der Veen Intrapericardial delivery of amiodarone and sotalol: atrial transmural drug distribution and electrophysiological effects J Cardiovasc Pharmacol 54 2009 355 363
9. V. Labhasetwar, T. Underwood, M. Gallagher, G. Murphy, J. Langberg, and R.J. Levy Sotalol controlled-release systems for arrhythmias: in vitro characterization, in vivo drug disposition, and electrophysiologic effects J Pharm Sci 83 1994 156 164
10. Dias AA, Boerakker M, Nijenhuis AJ. Polymers comprising thioester bonds. Patent Cooperation Treaty/European Patent:2006/008730.
11. R.W. Bolderman, J.J. Hermans, and J.G. Maessen Determination of the class III antiarrhythmic drugs dronedarone and amiodarone, and their principal metabolites in plasma and myocardium by high-performance liquid chromatography and UV-detection J Chromatogr B Analyt Technol Biomed Life Sci 877 2009 1727 1731
12. A. Sintov, W. Scott, M. Dick, and R.J. Levy Cardiac controlled release for arrhythmia therapy: lidocaine-polyurethane matrix studies J Control Release 8 1988 157 165
13. R. Siden, W.E. Flowers, and R.J. Levy Epicardial propranolol administration for ventricular arrhythmias in dogs: matrix formulation and characterization Biomaterials 13 1992 764 770
14. R. Siden, A. Kadish, W. Flowers, L. Kutas, B.K. Bieneman, and J. DePietro Epicardial controlled-release verapamil prevents ventricular tachycardia episodes induced by acute ischemia in a canine model J Cardiovasc Pharmacol 19 1992 798 809
15. V. Labhasetwar, T. Underwood, R.W. Heil Jr., M. Gallagher, J. Langberg, and R.J. Levy Epicardial administration of ibutilide from polyurethane matrices: effects on defibrillation threshold and electrophysiologic parameters J Cardiovasc Pharmacol 24 1994 826 840
16. M. Hendrikx, U. Mees, A.C. Hill, B. Egbert, G.T. Coker, and T.D. Estridge Evaluation of a novel synthetic sealant for inhibition of cardiac adhesions and clinical experience in cardiac surgery procedures Heart Surg Forum 4 2001 204 210
17. C.G. Pitt, M.M. Gratzl, G.L. Kimmel, J. Surles, and A. Schindler Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo Biomaterials 2 1981 215 220
18. P.C. Adams, D.W. Holt, G.C. Storey, A.R. Morley, J. Callaghan, and R.W. Campbell Amiodarone and its desethyl metabolite: tissue distribution and morphologic changes during long-term therapy Circulation 72 1985 1064 1075
19. I. Kodama, K. Kamiya, and J. Toyama Cellular electropharmacology of amiodarone Cardiovasc Res 35 1997 13 29
20. J.P. Mathew, M.L. Fontes, I.C. Tudor, J. Ramsay, P. Duke, and C.D. Mazer A multicenter risk index for atrial fibrillation after cardiac surgery JAMA 291 2004 1720 1729
21. G. Zhang, Y. Nakamura, X. Wang, Q. Hu, L.J. Suggs, and J. Zhang Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart Tissue Eng 13 2007 2063 2071
22. K. Kikuchi, A.D. McDonald, T. Sasano, and J.K. Donahue Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer Circulation 111 2005 264 270
23. I. Kutschka, I.Y. Chen, T. Kofidis, T. Arai, G. von Degenfeld, and A.Y. Sheikh Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts Circulation 114 2006 I167 I173
24. C. Spadaccio, M. Chello, M. Trombetta, A. Rainer, Y. Toyoda, and J.A. Genovese Drug releasing systems in cardiovascular tissue engineering J Cell Mol Med 13 2009 422 439
25. M.R. Franz, P.L. Karasik, C. Li, J. Moubarak, and M. Chavez Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter J Am Coll Cardiol 30 1997 1785 1792